Xconomy (Free subscription) | 11/04/2009
There’s big news about Enlight Biosciences breaking here at the Xconomy Forum: Pharma’s Bet on Boston Innovation. Abbott Laboratories (NYSE:ABT) has joined the consortium of big pharmas that are supporting Enlight, according to CEO David Steinberg; the Boston-based startup is out to develop platform technologies to help large drug companies like Abbott streamline the processes [...]
MarketIntelligenceCenter.com (Free subscription) | 10/26/2009
Abbott Laboratories (NYSE: ABT) ended the last trading session at $51.31. So far the stock has hit a 52-week low of $41.27 and 52-week high of $57.40. Abbott Laboratories stock has been showing support around 50.28 and resistance in the 52.68 range. Technical indicators for the stock are Bullish and S&P gives ABT a positive 4 STAR (out of 5) buy rating. ABT appears on the Investors Observer Analysts...
Market Wire (Free subscription) | 10/19/2009
SUGAR LAND, TX (MARKET WIRE) Researched by Industrial Info Resources (Sugar Land, Texas) -- Global pharmaceutical companies Baxter International Incorporated (NYSE: BAX) (Deerfield, Illinois) and Abbott Laboratories (NYSE: ABT) (Abbot Park, Illinois) this week reported earnings for the third quarter of their 2009 fiscal years. Although negative foreign exchange reduced both companies' bottom lines,...
BloggingStocks (Free subscription) | 10/17/2009
Filed under: Earnings reports , Google (GOOG) , General Electric (GE) , Intel (INTC) , International Business Machines (IBM) , Nokia Corp. (NOK) , Citigroup Inc. (C) , Johnson and Johnson (JNJ) , JPMorgan Chase (JPM) , Advanced Micro Dev (AMD) , Abbott Laboratories (ABT) , Bank of America (BAC) , Domino's Pizza (DPZ) , Goldman Sachs Group (GS) , Mattel, Inc (MAT) , Allegheny Technologies (ATI) , Harley-Davidson...
Jim Cramer's Mad Money (Free subscription) | 10/16/2009
Jim Cramer’s Mad Money Stock Picks for Thursday October 15 2009. These are all of Jim Cramer’s stock picks that are a Buy! I bold my picks. Buy: FLIR Systems (FLIR) Warner Chilcott (WCRX) Abbott Laboratories (ABT) McDonald’s (MCD) Wendy’s/Arby’s Group (WEN) Xilinx (XLNX) Google (GOOG) Sell: Johnson & Johnson (JNJ) Yum! Brands (YUM) International Bancshares (IBOC) Suntech...
SeekingAlpha.com (Free subscription) | 10/14/2009
Abbott Laboratories ( ABT ) Q3 2009 Earnings Call October 14, 2009 9:00 am ET Complete Story »
Investment U (Free subscription) | 10/14/2009
Two Pharmas Are Better Than One… Here Are the Ones to Buy in This Merger-Mad Industry Tony Daltorio, Investment U Research Pharmaceutical companies have launched themselves into the fall season with a vengeance, gobbling up acquisitions like dots on a Pac-Man board. The most notable recent buyout was a deal that sees Abbott Laboratories [...]
BloggingStocks (Free subscription) | 10/14/2009
Filed under: Earnings reports , Forecasts , Abbott Laboratories (ABT) Plenty of companies are reporting earnings this Wednesday morning, one of which is Abbott Laboratories (NYSE: ABT ). The health-care giant reported third-quarter earnings of 95 cents per share, far better than last year's 69 cents per share. Taking items out of the equation, Abbott would have earned 92 cents per share , which is...
MarketIntelligenceCenter.com (Free subscription) | 10/14/2009
Abbott Laboratories (NYSE: ABT) opened at $50.72. So far today, the stock has hit a low of $50.24 and a high of $51.45. ABT is now trading at $51.36, up $1.71 (3.44%). The stock hit its 52-Week high of $58.24 last October and set its 52-Week low of $41.27 in May. Abbott is trading sharply higher today after the company beat analyst estimates this morning by two pennies, with a...
Market Watch (Free subscription) | 10/14/2009
A surprisingly strong profit and outlook from Intel and much stronger-than-forecast results from J.P. Morgan Chase sent U.S. stock futures rallying Wednesday and put a 10,000 level on the Dow Jones Industrial Average within reach. See Indications
banks-of-uk.com (Free subscription) | 10/14/2009
(Updates with details and background throughout)Abbott Laboratories (ABT) reported a 36% increase in third-quarter profit, helped by higher sales of nutritional products and heart devices
Seeking Alpha (Free subscription) | 10/14/2009
Abbott Laboratories ( ABT ): Q3 EPS of $0.92 beats by $0.02 . Revenue of $7.76B (+3.5%) in-line. Shares +3% premarket. ( PR ) Post your comment!
BloggingStocks (Free subscription) | 10/14/2009
Filed under: Earnings reports , Forecasts , Abbott Laboratories (ABT) Abbott Laboratories (NYSE: ABT ), the broad-based health care company that produces both Humira and Similac, is scheduled to discuss its third quarter 2009 financial results in a conference call Wednesday at 9:00 AM ET. You can catch the live webcast on the company's website . During the three months that ended in September, Abbott...
BloggingStocks (Free subscription) | 10/12/2009
Filed under: Newsletters , Abbott Laboratories (ABT) , Baxter Intl (BAX) , Bristol-Myers Squibb (BMY) , Gilead Sciences (GILD) , Stocks to Buy "Being contrarians, we are always looking for laggard stocks with the potential to rebound," says turnaround expert George Putnam . In his The Turnaround Letter , the advisor reviews four medical and pharmaceutical stocks that have been among the...
MarketIntelligenceCenter.com (Free subscription) | 10/12/2009
Abbott Laboratories (ABT) appears to be on the move today and is now at $50.19, up $0.10 (0.20%) on volume of 616,688 shares traded. Over the last 52 weeks the stock has ranged from a low of $41.27 to a high of $58.24. ABT was covered in a Vic Wisemann report today. To read the report, and see Vic's earnings season preview, go to www.marketintelligencecenter.com/vw101209 . Abbott Laboratories stock...
Videos